• Log In
  • Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Mukherjee Labs Preclinical Imaging

Design and Development of Novel Imaging Methods for Early Diagnosis of Diseases

  • Mukherjee Labs – Preclinical Imaging
  • Research
    • Biomarkers Research and Development
    • Radiopharmaceutical Research
    • Pharmacology and Neuroscience
    • Autoradiography
    • Small Animal PET Imaging
    • Small Animal CT Imaging
    • Small Animal SPECT/CT
    • Human Brain & Whole Body PET Imaging
    • Bioluminescence and Fluorescence Optical Imaging
    • Data Sharing
  • People
    • Current Members
    • Former Members
  • Publications
    • Meeting Presentations
    • Schizophrenia
    • Alzheimer’s Disease
    • Parkinson’s Disease
    • Cancer
    • Diabetes & Obesity
  • News
    • Student Excellence in Research April 2025
    • Focused Ultrasound machine Feb 2025
    • UROP Symposium May 2024
    • Inveon Embedded PET/CT April 2024
    • Tau Imaging Research February 2024
    • New Hot Cells Installed May 2023
    • UROP UCI Symposium May 2023
    • Letter from US Congress; August 16, 2022
    • SNMMI 2022, JUNE 11-14
    • UROP Symposium May 2022
    • NRM 2021 December 14-16
    • Society for Neuroscience Mtg Nov 2021
    • WMIC, October 5-8, 2021
    • SNMMI Annual Meeting, June 12-15, 2021
    • Flotaza for Alzheimer’s disease
    • UROP UCI Symposium_ May 21, 2021
    • GE TracerLab FXN Installed 12/01/2020
    • New DCE Mini Hot Cell Installed 11/11/2020
    • World Molecular Imaging Conference (WMIC), 10/7/2020
    • New Inveon SPECT/CT Scanner Installed 9/23/2020
    • SNMMI Virtual Annual Meeting 2020, July 11-14
    • Metz Lectures, University of Chicago, Feb 4 and 5, 2020
    • 5th Int Symposium on Acetylcholine, Sept 27-29, 2019
    • SNMMI Annual Meeting, June 22-25, 2019
    • UROP UCI Symposium_ May 18, 2019
    • UROP UCI Symposium_ May 19, 2018
    • AALAS Imaging Workshop May 9, 2018
    • New Website
  • Support
  • Contact Us
You are here: Home / Mukherjee Lab – Preclinical Imaging / Research / Bioluminescence and Fluorescence Optical Imaging

Bioluminescence and Fluorescence Optical Imaging

In vivo fluorescence imaging is being used to optimize biomarkers for PET and assist in longitudinal studies. An in vivo Kodak imaging system F (Image Station 4000MM) is used for these studies. The system features 5-position excitation filter slider with two excitation filters of choice, 4-position emission filter wheel with two proprietary wide-angle emission filters of choice, external 150-watt halogen illumination source and mounted fiber-optic light guides, PC computer with 17-inch flat-panel monitor, KODAK Molecular Imaging Software. The CCD camera presents 4.2 megapixel resolution, true 16-bit imaging and high sensitivity.

Multimodality Imaging Probe:  Structure of BSA-Biotin-DTPA-FAM during the process of radiochelation with 68GaCl3 to form BSA-Biotin-DTPA-FAM-68Ga.

Imaging of rodents with Multimodality probe: Left: Fluorescence Image: Bright spots at both flanks: one for FAM conjugate (50µL) and other for FAM-68Ga conjugate (50µL). Right: MicroPET image: only one hot spot at the expected flank (FAM-68Ga conjugate 30µCi; 25µCi of 18F was also injected (iv) for skeletal uptake).

Potential Fluorescence Imaging Agents for α4β2 nicotinic receptors: A. Minimized energy structure of nifrolidine, 3 with reported high affinity for a4b2* receptors; B. Energy minimized structure of nifrodansyl, 4, in which the fluorine atom in 3 is replaced with the fluorescent moiety, dansylamide (marked in green bracket in 4). C. Energy minimized structure of nifrofam, 5, in which the fluorine atom in 3 is replaced with the fluorescent moiety, carboxyfluorescein (FAM, marked in green bracket in 5).

α4β2HA stable cells – live labeling and live cell imaging: HEK cells stably expressing α4β2HA nicotinic receptor subtypes were untreated (top panel, A-C) or treated with nicotine (10 mM for 17 hr; bottom panel, D-F). Nicotine was washed off prior to labeling the live cells with antibody or ligand. Cell surface receptors were labeled with anti-HA (b2 subunit has an HA tag at the extracellular C-terminus tail) followed by Nifrofam (100 nM) and Alexa Fluor 568 anti-rabbit secondary antibody.

 

 

Primary Sidebar

Translational PET

Inveon PET

Inveon CT

Inveon SPECT/CT

ECAT HR+ PET

Molecular Imaging

Mukherjee Labs

Preclinical Imaging
Radiological Sciences
University of California Irvine
Irvine, CA 92697-5000
email: j.mukherjee@uci.edu
Tel: 949-824-2018

© 2025 UC Regents